


New Data Highlight Effectiveness of Guselkumab for Patients with PsA

FDA Approves Secukinumab for Children with Enthesitis-Related Arthritis & PsA
Risk of IBD in Patients with Psoriasis, PsA & Ankylosing Spondylitis Starting IL-17 Inhibitors
Risankizumab Effective Against Refractory Psoriatic Arthritis

Care of Patients with Spondyloarthritis

The Big Picture: How to Assess Disease Activity in Patients with axSpA & PsA in Clinical Practice

New Supplement to The Rheumatologist Highlights Psoriatic Arthritis Advances

Minimizing Disease Activity in Psoriatic Arthritis

A Dematologist’s Perspective on Choosing an Anti-Psoriatic Drug
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 16
- Next Page »